Black Book Research Q4 flash survey shows health plans shifting from effort-based sourcing to KPI-backed operating models, ...
Discover why Abbott Laboratories (ABT) earns a buy rating with strong fundamentals, dividend growth, and growth prospects.
Daniel Liberto is a journalist with over 10 years of experience working with publications such as the Financial Times, The Independent, and Investors Chronicle. Amy is an ACA and the CEO and founder ...
The Harbor Small Cap Growth Fund returned 7.63% in Q3 2025, trailing its benchmark amid a speculative market rally. Click ...